Concepedia

Hiroyuki Okabe

HO

Statistics

Publications

20

Citations

972

H-Index

16

Active since

1994

Affiliations

Taiho Pharmaceutical (Japan)(Current)

Keio University

Nagoya University

Hiroyuki Okabe is an author at Taiho Pharmaceutical (Japan) specializing in medicine, cancer research, and oncology.

Top concepts

Publications per year

1994–2019

20

Publications

20

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

Nozomu Tanaka, Kazuki Sakamoto, Hiroyuki Okabe et al. · Oncology Reports · 2014 · 140 citations · Full text

, , +14

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

Hiroshi Tsukihara, Fumio Nakagawa, Kazuki Sakamoto et al. · Oncology Reports · 2015 · 109 citations · Full text

, , +12

Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5‐Fluorouracil

Yoichiro Ishikawa, Tetsuro Kubota, Yoshihide Otani et al. · Japanese Journal of Cancer Research · 2000 · 93 citations · Full text

, , +16

Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro.

Hiroki Abe, Kenji Okajima, Hiroyuki Okabe et al. · PubMed · 1994 · 86 citations

An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA

Tomohiro Emura, Fumio Nakagawa, Akio Fujioka et al. · International Journal of Molecular Medicine · 2004 · 85 citations

, , +21

1–5 of 20